A discovery & pre-clinical-stage company and a pioneer in the development of transformative pan-cancer therapies that target the tumor microenvironment removing barriers and inducing intra-tumoral immune architecture for effective full-circle immunotherapy. We focus on the discovery, design and engineering of catalytic immune effectors systems.
Glycocalyx
